{"doi":"10.1002/ana.25751","title":"Clinico‐Genetic, Imaging and Molecular Delineation of <scp><i>COQ8A</i></scp>‐Ataxia: A Multicenter Study of 59 Patients","abstract":"OBJECTIVE: To foster trial-readiness of coenzyme Q8A (COQ8A)-ataxia, we map the clinicogenetic, molecular, and neuroimaging spectrum of COQ8A-ataxia in a large worldwide cohort, and provide first progression data, including treatment response to coenzyme Q10 (CoQ10). METHODS: Cross-modal analysis of a multicenter cohort of 59 COQ8A patients, including genotype-phenotype correlations, 3D-protein modeling, in vitro mutation analyses, magnetic resonance imaging (MRI) markers, disease progression, and CoQ10 response data. RESULTS: Fifty-nine patients (39 novel) with 44 pathogenic COQ8A variants (18 novel) were identified. Missense variants demonstrated a pleiotropic range of detrimental effects upon protein modeling and in vitro analysis of purified variants. COQ8A-ataxia presented as variable multisystemic, early-onset cerebellar ataxia, with complicating features ranging from epilepsy (32%) and cognitive impairment (49%) to exercise intolerance (25%) and hyperkinetic movement disorders (41%), including dystonia and myoclonus as presenting symptoms. Multisystemic involvement was more prevalent in missense than biallelic loss-of-function variants (82-93% vs 53%; p = 0.029). Cerebellar atrophy was universal on MRI (100%), with cerebral atrophy or dentate and pontine T2 hyperintensities observed in 28%. Cross-sectional (n = 34) and longitudinal (n = 7) assessments consistently indicated mild-to-moderate progression of ataxia (SARA: 0.45/year). CoQ10 treatment led to improvement by clinical report in 14 of 30 patients, and by quantitative longitudinal assessments in 8 of 11 patients (SARA: -0.81/year). Explorative sample size calculations indicate that ≥48 patients per arm may suffice to demonstrate efficacy for interventions that reduce progression by 50%. INTERPRETATION: This study provides a deeper understanding of the disease, and paves the way toward large-scale natural history studies and treatment trials in COQ8A-ataxia. ANN NEUROL 2020;88:251-263.","journal":"Annals of Neurology","year":2020,"id":57606,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":77,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.5414,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":301263,"name":"Tommaso Schirinzi","orcid":"0000-0002-2517-6278","position":1,"is_corresponding":false},{"id":301264,"name":"Lucia Laugwitz","orcid":"0000-0003-2506-1961","position":2,"is_corresponding":false},{"id":301265,"name":"Nathan H. Murray","orcid":"0000-0001-7185-2591","position":3,"is_corresponding":false},{"id":301266,"name":"C.A. Bingman","orcid":"0000-0002-3073-5089","position":4,"is_corresponding":false},{"id":301267,"name":"Selina Reich","orcid":"0000-0002-2693-4202","position":5,"is_corresponding":false},{"id":301268,"name":"Jan Marco Kern","orcid":"0000-0001-8526-3894","position":6,"is_corresponding":false},{"id":301269,"name":"Anna Heinzmann","orcid":"0000-0001-8007-2597","position":7,"is_corresponding":false},{"id":301270,"name":"Gessica Vasco","orcid":"0000-0001-9807-9578","position":8,"is_corresponding":false},{"id":284336,"name":"Enrico Bertini","orcid":"0000-0001-9276-4590","position":9,"is_corresponding":false},{"id":301271,"name":"Ginevra Zanni","orcid":"0000-0002-6367-1843","position":10,"is_corresponding":false},{"id":17559,"name":"Alexandra Dürr","orcid":"0000-0002-8921-7104","position":11,"is_corresponding":false},{"id":288193,"name":"Stefania Magri","orcid":"0000-0002-9610-7544","position":12,"is_corresponding":false},{"id":288167,"name":"Franco Taroni","orcid":"0000-0002-2420-5233","position":13,"is_corresponding":false},{"id":301272,"name":"Alessandro Malandrini","orcid":"0000-0003-1034-0845","position":14,"is_corresponding":false},{"id":301273,"name":"Jonathan Baets","orcid":"0000-0001-8295-5385","position":15,"is_corresponding":false},{"id":299862,"name":"Peter De Jonghe","orcid":null,"position":16,"is_corresponding":false},{"id":301274,"name":"Willem De Ridder","orcid":"0000-0003-2754-5302","position":17,"is_corresponding":false},{"id":301275,"name":"Matthieu Béreau","orcid":"0000-0003-0769-0289","position":18,"is_corresponding":false},{"id":303167,"name":"Stephanie Demuth","orcid":null,"position":19,"is_corresponding":false},{"id":301276,"name":"Christos Ganos","orcid":"0000-0001-8077-8530","position":20,"is_corresponding":false},{"id":301277,"name":"A. Nazlı Başak","orcid":"0000-0001-6977-2517","position":21,"is_corresponding":false},{"id":295718,"name":"Haşmet Hanağası","orcid":"0000-0002-4624-4428","position":22,"is_corresponding":false},{"id":301278,"name":"Semra Hız Kurul","orcid":"0000-0002-8020-4884","position":23,"is_corresponding":false},{"id":241344,"name":"Benjamin Bender","orcid":"0000-0002-3205-4631","position":24,"is_corresponding":false},{"id":301279,"name":"Lüdger Schöls","orcid":"0000-0001-7774-5025","position":25,"is_corresponding":false},{"id":303168,"name":"Ute Grasshoff","orcid":null,"position":26,"is_corresponding":false},{"id":282682,"name":"Thomas Klopstock","orcid":"0000-0003-2805-4652","position":27,"is_corresponding":false},{"id":18312,"name":"Rita Horváth","orcid":"0000-0002-9841-170X","position":28,"is_corresponding":false},{"id":303169,"name":"Bart van de Warrenburg","orcid":null,"position":29,"is_corresponding":false},{"id":242566,"name":"Lydie Bürglen","orcid":"0000-0002-1119-6809","position":30,"is_corresponding":false},{"id":301280,"name":"Christelle Rougeot","orcid":"0009-0009-0866-5238","position":31,"is_corresponding":false},{"id":301281,"name":"Claire Ewenczyk","orcid":"0000-0002-4864-6287","position":32,"is_corresponding":false},{"id":303170,"name":"Michel Kœnig","orcid":null,"position":33,"is_corresponding":false},{"id":301282,"name":"Filippo M. Santorelli","orcid":"0000-0002-1359-9062","position":34,"is_corresponding":false},{"id":17555,"name":"Mathieu Anheim","orcid":"0000-0001-8121-0605","position":35,"is_corresponding":false},{"id":301283,"name":"Renato P. Munhoz","orcid":"0000-0002-4783-4067","position":36,"is_corresponding":false},{"id":57003,"name":"Tobias B. Haack","orcid":"0000-0001-6033-4836","position":37,"is_corresponding":false},{"id":301284,"name":"Felix Distelmaier","orcid":"0000-0003-4304-7848","position":38,"is_corresponding":false},{"id":253457,"name":"David J. Pagliarini","orcid":"0000-0002-0001-0087","position":39,"is_corresponding":false},{"id":301285,"name":"Hélène Puccio","orcid":"0000-0003-4711-2248","position":40,"is_corresponding":false},{"id":65630,"name":"Matthis Synofzik","orcid":"0000-0002-2280-7273","position":41,"is_corresponding":false},{"id":301262,"name":"Andreas Traschütz","orcid":"0000-0002-8165-5898","position":0,"is_corresponding":true}],"reference_count":41,"raw_metadata":null,"created_at":"2026-07-18T21:06:48.611399Z","pmid":"32337771","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}